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Background: Rheumatoid arthritis is characterized by the presence of circulating auto-antibodies, including
rheumatoid factors, which recognize the Fc portion of IgGs. The neutrophil is the most abundant circulating
leukocyte and it expresses high levels of FcγRs on its surface. The aim of the present study was to examine the
capacity of circulating human neutrophils to be activated by rheumatoid factors and the consequences of these
events on endothelium.
Methods: Neutrophil-bound IgGs were cross-linked with anti-human IgGs to mimick the presence of circulating
rheumatoid factors and FcγRs-dependent signalling events and functions were examined. The IgG and IgM
composition of rheumatoid factors isolated from the serum of RA patients was characterized. Adhesion of
neutrophils to endothelial cells was quantified in response to the addition of rheumatoid factors.
Results: Cross-linking of IgGs bound on neutrophils leads to FcγRs-dependent tyrosine phosphorylation,
mobilisation of intracellular calcium and the extracellular release of superoxide anions and lysozyme. Incubation of
endothelial cells with the supernatant of activated neutrophils increases ICAM-1 expression and IL-8 production by
endothelial cells. Finally, rheumatoid factors enhance neutrophil adhesion to endothelial cells.
Conclusions: Our results show that activation of neutrophils’ FcγRs by rheumatoid factors could participate in
rheumatoid arthritis-associated vascular damage.
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Rheumatoid arthritis (RA) is a chronic auto-immune in-
flammatory disease whose origin remains poorly under-
stood. It is characterized by infiltration of leukocytes
(mostly neutrophils) in the joints and a proliferation of
the lining synovial cells often leading to the irreversible
destruction of cartilage and bone. RA also has systemic* Correspondence: emmanuelle.rollet@crchul.ulaval.ca
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distribution, and reproduction in any mediummanifestations [1-3]. Vascular inflammation is a severe
complication of RA and patients with RA show an in-
creased risk for cardiovascular events compared with
the general population [4-6].
There is long-standing evidence for the presence of
increased titers of auto-antibodies in the serum of RA
patients. The best known are rheumatoid factors (RFs) and
anti-cyclic citrullinated peptide (anti-CCP) antibodies the
quantitation of which is currently used for clinical diagnos-
tic purposes [7]. Results obtained with animal models point
to a crucial role for these antibodies in the pathology of
arthritis [8,9]. Rheumatoid factors recognize the Fc portionentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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patients and represent a diagnostic and prognostic marker
for RA even though they are detected in other auto-
immune diseases and systemic infections [10]. RFs can
enhance immune complex formation by interacting with
circulating free IgGs, which are present at high concentra-
tions (10 mg/ml) in human serum [11].
FcγRs specifically recognize the Fc portion of IgGs.
Neutrophils, the most abundant circulating leukocytes,
express at their surface high amounts of a specific and
unique combination of FcγRs, namely FcγRIIa and
FcγRIIIb. These receptors play key roles in neutrophil
phagocytosis as they participate in the recognition and
phagocytosis of pathogens opsonized with IgGs. Neu-
trophils also possess a battery of cytotoxic enzymes that
can be delivered within intracellular phagosomes to ef-
fect killing but may be inadvertently released extracellu-
larly with deleterious consequences for the surrounding
tissues [12]. FcγRs can also recognize naturally occurring
immune complexes (ICs) and they play key roles in auto-
immunity as they participate in the clearance of immune
complexes which are abundant in the joint and circulation
of RA patients [13,14]. Recently, an association of FcγRIIIb
copy number with the susceptibility to RF-positive RA
was reported [15].
Since neutrophils are the major cells which infiltrate
the synovial fluid and tissues [16] in RA, the activation
of FcγRs on neutrophils is likely to play an important
role in the chronic nature and the severity of the disease.
Several murine models have been developed to test this
hypothesis and to define the specific contribution of the
different FcγRs [17,18]. Mice deficient in the common
γ-signalling chain of FcγRs are not susceptible to arthritis
induction; in contrast, the lack of the inhibitory receptor
FcγRIIb exacerbates collagen-induced arthritis in suscep-
tible mice [19]. However, as mouse and human FcγRs differ
in their expression and cellular distribution, it is difficult to
extrapolate results observed in mouse models to human
diseases. Nevertheless, FcγRIIa has been implicated in
RA as human FcγRIIa transgenic mice are susceptible to
collagen-induced arthritis [19,20]. Neutrophil-selective
transgenic expression of human FcγRIIa and FcγRIIIb in
this model indicates that these two receptors play non-
redundant roles [13]. Belostocki et al. observed that FcγRIIa
expression on circulating neutrophils was decreased during
a longitudinal follow-up of RA patients receiving four
infliximab infusions [21].
These data, together with the known role of neutrophils
in tissue injury in IgG-mediated diseases and atheroscler-
osis, indicate that a detailed examination of the role of
RFs on neutrophils and their potential implication in
RA-associated vascular damage is warranted [22,23].
Whereas most of the neutrophil studies examine their
roles outside the blood vessels, circulating neutrophilscan have a pathological function in the systemic in-
flammatory condition that is characteristic of RA. In
RA, circulating ICs first deposit in vasculature and
FcγRIIIb plays an important role in slowing down neu-
trophils leading to adhesion [24-26]. Neutrophils can
then signal cytotoxic functions through, among others,
FcγRs thus promoting tissue damage [27]. These data
contributed to the elaboration of our hypothesis that
IC and RF-containing IC can activate FcγRs on circu-
lating neutrophils and participate in the development




The anti-phosphotyrosine antibody (4G10, catalog
no.05-321X) was purchased from Millipore (Billerica, MA).
Horseradish peroxidase-labelled sheep anti-mouse IgGs
(catalog no.NXA931) was obtained from GE Healthcare
(Uppsala, Sweden). The anti-actin antibody (sc-1616) was
obtained from Santa-cruz Biotechnology (Santa Cruz, CA).
The anti-ICAM1 antibody (catalog no.BBA4) was obtained
from R&D systems (Minneapolis, MN). Horseradish
peroxidase-labelled anti-human IgGs, anti-human IgMs
and anti-goat IgGs, FITC-labelled anti-human IgGs
(catalog no.109-096-097) and anti-mouse IgGs (catalog
no.115-096-071) and the rabbit anti-human IgGs (H + L)
(catalog no.309-005-082) and rabbit anti-human IgGs, Fc
fragment specific (catalog no.309-005-008) were obtained
from Jackson ImmunoResearch (West Grove, PA). The
anti-FcγRIIIb Pelicluster (clone CLB-FcR-gran/1) (catalog
no. M1389) was purchased from Sanquin (Amsterdam,
The Netherlands). The anti-FcγRIIa antibody (clone IV.3)
was purified from ascites of mice inoculated with hybridoma
HB-217 obtained from the American Type Culture
Collection (Manassas, VA).
Reagents
Calcein AM and Fura-2 AM were obtained from Invitrogen
Life technologies (Burlington, ON). Cytochrome c was
purchased from EMD chemicals (Mississauga, ON).
Dextran T-500 and Micrococcus lysodeikticus were pur-
chased from Sigma (Oakville, ON). Western lightning
chemiluminescence plus was obtained from Perkin Elmer
(Boston, MA). Ficoll-Paque and Hepes were obtained from
Wisent (St-Bruno, QC).
Isolation and stimulation of neutrophils
The collection of the blood was done with an appropriate
consent form and approval of Laval University ethics
committee. Neutrophils were aseptically isolated from
healthy donors as previously described [28]. They were
resuspended at 20x106 cells/ml in Mg2+-free HBSS
containing 1.6 mM of CaCl2. Autologous platelet-poor
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plasma at 3000xg for 10 minutes. To restore the physio-
logic amounts of bound IgGs on isolated cells, neutrophils
were incubated for 20 minutes on ice with 10% autologous
PPP followed by a 2 minutes centrifugation at 600xg. The
neutrophils’ FcγRs were cross-linked by incubation with
rabbit anti-human IgGs (20 μg/ml, final concentration) or
with RFs (500 μg/ml) at 37°C for the times indicated in the
legends of the figures. For FcγRs blocking experiments,
antibodies IV.3 (2 μg/ml) (anti-FcγRIIa) and Pelicluster
(4 μg/ml) (anti-FcγRIIIb) were added 10 minutes before
incubation with autologous PPP. For the preparation of
neutrophil supernatants, IgG were cross-linked with
rabbit anti-human IgG antibody for 30 minutes at 37°C
in the presence of 0.5% BSA. Neutrophils were then
centrifuged (13000xg, 1 minute) and supernatants were
collected and re-centrifuged before filtration on 0.22 μM
membranes.
Electrophoresis and immunoblotting
Proteins were separated by SDS-PAGE on 7.5-15% or 10%
acrylamide gels and transferred on PVDF membranes.
They were then analyzed by immunoblotting as described
in the legends of the figures.
Calcium mobilisation
Neutrophils were pre-incubated with 1 μM fura-2 AM
for 30 minutes at 37°C in the presence of 0.5% BSA. The
extracellular probe was removed by centrifugation and the
cells were resuspended in HBSS at 5x106 cells/ml and stim-
ulated as described in the legend of the figures. Fluores-
cence was monitored in a fluorescence spectrophotometer
(Fluorolog-SPEX from Jobin Yvon Inc., Edison, NJ) using
two excitation wavelengths of 340 and 380 nm and an
emission wavelength of 510 nm. The ratio of fluorescence
values obtained at 340 and 380 nm was used as a measure
of the intracellular levels of free cytoplasmic calcium.
Degranulation
The extent of lysozyme release was assessed by adding
100 μl of neutrophil supernatants to 900 μl of a 0.25mg/ml
Micrococcus lysodeikticus solution prepared in a 0.1M PO4
buffer. The loss of absorbance was then monitored at 450
nm for 5 minutes and the rate of decrease of the absorbance
provided a measure of the lysozyme activity present in the
supernatants. The slopes were normalized to that of a cell
lysate obtained by lysing the cells with 0.1% Triton X-100.
Superoxide production
Superoxide production was measured using the cyto-
chrome c reduction assay. The absorption of cytochrome
c was monitored at 550 nm and 540 nm and the amount
of superoxide anions produced was calculated from the
difference between the OD at the two wavelengths.Culture and stimulation of HUVECs
Human umbilical vein endothelial cells (HUVECs) were
obtained from Lonza (Basel, Switzerland). They were
cultured in a humid atmosphere containing 5% CO2 in
EGM medium complemented with bovine brain extract
as indicated by the company and used at passages 2–6.
For the measurement of ICAM-1 expression and IL-8
production, HUVECs were seeded at 13x104cells/well in
6-well plates, grown for 24 hours and stimulated for 24
hours with the supernatants of control or IgGs-cross-linked
human neutrophils diluted 1:1 in EGM complete medium.
After stimulation, the supernatants of the HUVECs were
collected and the cells were stimulated for another 24 hours
with a new aliquot of the same supernatants of control or
IgGs cross-linked human neutrophils diluted 1:1 in EGM
complete medium following which the supernatants of the
HUVECs were collected again.
Adhesion of neutrophils to endothelial cells
To obtain confluent monolayers, endothelial cells were
seeded at 4–5 000 cells/well in 96-well plates and grown
for 72–96 hours. Isolated neutrophils (20x106/ml) were
labeled in HBSS containing 5 μM calcein AM for 30 mi-
nutes at 37°C in the dark. PPP (10%, final concentration)
was added to the neutrophil suspension for 20 minutes
on ice following which the neutrophils were centrifuged
and resuspended (5x106/ml) in HBSS containing 0.8 mM
MgCl2. Neutrophils (25x10
4 cells) were then added to
the 96-well plates containing the confluent HUVEC
monolayers and stimulated with anti-human IgGs antibody
for 30 minutes or RFs for two hours at 37°C in a humid
atmosphere containing 5% CO2 in the dark. Non-adherent
cells were washed away with cold PBS and the fluorescence
of the plates resulting from the adhesion of calcein-labelled
neutrophils to HUVECs was monitored at 485/530 nm
(excitation/emission).
Preparation of rheumatoid factors
The collection of the blood was done with an appropriate
consent form and approval of McGill University ethics
committee. Selected sera from RF positive RA patients
were pooled and centrifuged at 10,000 rpm for 15 minutes
to remove any particulate matter. The supernatant was
then made to a final concentration of 5% polyethylene
glycol 6000 (by adding an equal volume of 10%) and mixed
well. After 16 hrs at 4°C, the precipitates were collected by
centrifugation for 15 minutes at 10,000 rpm. These precipi-
tates were resuspended in PBS/azide to the original volume
of the serum or plasma (and thus diluting out the PEG).
The semi-purified RF-containing solutions were then stored
at −20°C in a 50% glycerol solution to prevent damage from
freeze thawing. Pentameric IgM precipitates at 5% PEG,
whereas free IgG requires 10-12% PEG in order to precipi-
tate from solution, thus the complexes collected using 5%
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nition, although IgG RF complexes may also be present.
Results
As RFs recognize the Fc portion of IgG, they can form
IC with circulating IgGs and deliver IgGs to neutrophils
potentially leading to the activation of FcγR-dependent
signalling pathways and functions. Alternatively, RFs
may directly recognize surface-bound IgGs, cross-link them
and, in so doing, activate neutrophils. Indeed, because
of the high concentration of IgGs in plasma (10 mg/ml),
neutrophils carry surface-bound IgGs in spite of the low
affinity of FcγRs for monomeric IgGs. Although IgGs
are dissociated from neutrophils after several washing steps
[29], we postulated that incubation of isolated neutrophils
with autologous plasma could restore the level of bound
IgGs to that physiologically present on circulating neu-
trophils. We measured the amount of IgGs on freshly
isolated neutrophils incubated with 10% of autologous
PPP and compared it with the amount of IgGs measured
on blood neutrophils (Figure 1A). The data confirm the
loss of surface-bound IgGs on isolated neutrophils and
indicate that incubation with 10% PPP leads to a recovery
of an amount of bound IgGs similar to that present on
circulating neutrophils. Furthermore, we also showed that
plasma IgGs specifically bind to FcγRs as blocking these
receptors with a combination of specific blocking anti-
bodies to both anti-FcγRIIa and anti-FcγRIIIb abrogated
the binding of IgGs to isolated neutrophils (Figure 1B).
To test the hypothesis that the presence of RFs can
lead to the activation of circulating neutrophils via their
FcγRs, we used commercially available rabbit antibodies
with the same antigenic characteristics as RFs, i.e. anti-
human IgG antibodies. We first examined whether these
antibodies could stimulate FcγR-dependent signalling
pathways in human neutrophils. We previously showed
that the specific engagement of FcγRIIa or FcγRIIIbFigure 1 Circulating blood neutrophils constitutively possess IgGs bo
neutrophils in whole blood, erythrocytes were lysed by dilution of 900 μl o
NH4Cl, 21.5mM Tris, pH 7.4 as previously described [30]. After the blood be
centrifugation at 800 g. The amount of IgGs bound on neutrophils was me
antibodies. The same measurement was performed on isolated neutrophils
B: Neutrophils were pre-incubated with blocking FcγRs antibodies before in
mean +/− SEM of five independent experiments. *** P < 0.0005 (one-samp(cross-linking using monoclonal antibodies specific for
FcγRIIa and FcγRIIIb) leads to an increase of the tyrosine
phosphorylation pattern of whole neutrophils lysates and to
an intracellular mobilisation of calcium [31,32]. Figure 2 in-
dicates that the addition of the anti-human IgG antibodies
led to an enhancement of the FcγR-dependent tyrosine
phosphorylation profile (see the proteins in the 60 to 120
kDa range) as well as to an increase in the level of free cyto-
plasmic calcium in isolated neutrophils pre-incubated with
PPP. Both responses were decreased if the F(ab’)2 fragment
of the anti-human IgG antibodies rather than the complete
antibodies were used (Figure 2C and data not shown).
This result indicates that these FcγR-dependent signalling
pathways are in part activated by direct binding of anti-
human IgG antibodies to free FcγRs. Furthermore, these
responses were also decreased when neutrophils were not
pre-incubated with PPP (Figure 2D and data not shown)
confirming the capacity of anti-human antibodies to
cross-link surface-bound IgGs.
The release of granule-contained proteolytic enzymes
and the production of radical oxygen species are among
the major means by which neutrophils destroy patho-
gens. However, these two functions will be deleterious
for the cellular environment if misdirected (e.g., if these
products are released into the extracellular milieu). As
circulating neutrophils are continuously in contact with
the vascular endothelium, we asked whether, in the con-
text of RF-associated pathologies, cross-linking of surface-
bound IgGs on neutrophils could trigger functions which
impact on the integrity of the endothelium layer. It is
relevant in this context to note that the extracellular
release of lysozyme and superoxide anions has been de-
scribed in response to the activation of neutrophils’ FcγRs
[33-35]. We, therefore, examined these two functions in
response to incubation with anti-human IgG antibodies.
Cross-linking of surface-bound IgGs led to a 1.5 fold
increase of the release of lysozyme and a 6 fold increase ofund to their FcγRs. A: For the measurement of IgGs present on
f whole blood in 11 ml of an NH4Cl buffer containing 138.3 mM
came translucent, leukocytes were recovered by a 5 minute
asured by flow cytometry using FITC-labeled anti-human IgG
incubated with or without 10% autologous PPP for 20 minutes.
cubation with PPP and analysis as in A. Results are expressed as
le t test).
Figure 2 Cross-linking of IgGs bound to human neutrophils leads to FcγR-dependent tyrosine phosphorylation and calcium
mobilisation. A: Isolated neutrophils were incubated with 10% autologous PPP with or without FcγRs blocking monoclonal antibodies as
described in Methods and Figure 1. Cross-linking of surface-bound IgGs was achieved by the addition of anti-human IgG antibodies. The reaction
was stopped by transferring aliquots of the neutrophil suspensions directly in the same volume of boiling 2X concentrated modified Laemmli’s
buffer [33]. Whole cell lysates (2.5x105 cells in each lane) were analysed by SDS-PAGE and immunoblotted with anti-phosphotyrosine antibody
4G10 or anti-actin antibody (loading control). B: Isolated neutrophils were preincubated with Fura2-AM, followed by an incubation with or
without FcγRs blocking antibodies and with 10% autologous PPP. Anti-human IgG antibodies were added and fluorescence was monitored as
described in Methods. C: Cross-linking of surface-bound IgGs was achieved by the addition of either complete anti-human IgG antibodies or
F(ab’)2 fragment of anti-human IgG antibodies. D: Neutrophils were incubated with or without PPP before cross-linking of surface bound IgGs.
Results are representative of, at least, three independent experiments.
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pension over that of unstimulated cells (Figure 3). Both
functions were inhibited in the presence of anti-FcγRs
antibodies. These results illustrate the capacity of circulat-
ing neutrophils to release toxic compounds in the extra-
cellular milieu when present in conditions ressembling
those present in RA.
Adhesion of neutrophils to endothelial cells is required
in the context of innate immunity as neutrophils leave
the vasculature to reach the inflammatory site. In the
aseptic context of RA where blood-borne neutrophils
encounter circulating ICs, we postulated that neutrophils
will also be stimulated to adhere to the endothelium since
activation of FcγRs leads to an increase of the expression
and activation of adhesion molecules on neutrophils
[36]. We tested this hypothesis by measuring the adherence
of neutrophils to HUVECs. Calcein-labelled neutrophils
were stimulated and incubated with endothelial cells for 30
minutes. We observed an increased capacity of stimulated
neutrophils to adhere to endothelial cells (Figure 4).
The adhesion is inhibited when neutrophils were pre-
incubated with blocking anti-FcγR (Figure 4A) or anti-
CD18 (Figure 4B) antibodies. Although the influenceof blood flow is not considered in this static assay, this
result indicates that cross-linking of IgGs bound on
neutrophils leads to a β2-dependent adhesion of neu-
trophils to endothelial cells.
The results presented in Figure 3 show that neutro-
phils release superoxide anions and lysozyme into the
extracellular medium subsequently to the cross-linking
of surface-bound IgGs. Because of the capacity of stimu-
lated neutrophils to adhere to endothelium (Figure 4),
these mediators will be concentrated in the endothelial
microenvironment. Accordingly, we next decided to exam-
ine the capacity of FcγRs-activated neutrophils to modulate
the phenotype of endothelial cells. As we observed a β2
integrin-dependent increase in the adhesion of neutrophils
subsequently to FcγR cross-linking, we examined the ex-
pression on the endothelial cells of the adhesion molecule
ICAM-1, the counterpart of β2–integrins whose expression
on endothelial cells is increased in response to inflamma-
tory mediators [38]. We observed that ICAM-1 expression
is increased when HUVECs were incubated for 48 hours
with the supernatants of stimulated but not of control neu-
trophils (Figure 5A). We also measured the production of
IL-8 by HUVECs as this chemokine plays a major role in
Figure 3 Cross-linking of IgGs bound to human neutrophils leads to the secretion of superoxide anions and of lysozyme. Isolated
neutrophils were incubated with 10% autologous PPP in the presence or absence of FcγRs blocking antibodies. A: Neutrophils were resuspended
at 5x106 cells/ml in HBSS containing 125 μM of cytochrome c and anti-human IgGs antibodies for 10 minutes at 37°C. The reaction was stopped by
transfer on ice and the cells were removed by centrifugation. Results are expressed as mean +/− SEM of three independent experiments. * = P < 0.05
(Wilcoxon signed rank test). B: Anti-human IgG antibodies were added for 30 minutes and the neutrophil supernatants were prepared as described in
Material and Methods. Lysozyme release and superoxide production were quantified as described in Methods. Results are expressed as mean +/− SEM
of three independent experiments. * = P < 0.05 (Mann–Whitney test).
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bated with neutrophil supernatants prepared as described
above and IL-8 was measured by ELISA. We observed a
slight but significant increase of soluble IL-8 production by
HUVECs exposed to supernatants of stimulated neutro-
phils (Figure 5B). The amounts of IL-8 measured are likely
to represent an underestimate of the actual amounts pro-
duced as secreted IL-8 by HUVECs will bind to extracellu-
lar aminoglycans residues of these cells and therefore will
be undetectable by ELISA [38,39]. The release of IL-8 byFigure 4 Cross-linking of surface-bound IgGs leads to the adhesion o
plates until confluence. Neutrophils were incubated with calcein and with
(10 μg/ml) (B) before addition of PPP, as described in Methods. Neutrophil
IgG antibodies for 30 minutes. Non adherent neutrophils were discarded a
fluorescence bound to endothelial cells. Results are expressed as mean +/−
*** = P < 0.0005 (Mann–Whitney test).stimulated and unstimulated neutrophils was also measured
and the values were substracted from the amounts mea-
sured in the supernatants of HUVECs.
Although the presence of RFs is associated with the
severity of RA symptoms, very few studies have defined
a biologic or pathologic function of these antibodies [40].
The results presented above suggest that RFs either as
ligands of FcγRs or as antibodies recognizing membrane-
bound IgGs might activate neutrophils. To verify this
hypothesis, we decided to test the capacity of human RFsf neutrophils to endothelial cells. HUVECs were grown in 96 well
or without FcγRs blocking antibodies (A) or anti-CD18 antibody [37]
s were then added to endothelial cells in the presence of anti-human
nd the amount of adherent cells was quantified as the amount of
SEM of three independent experiments. * = P < 0.05, ** = P < 0.005,
Figure 5 ICAM-1 expression and IL-8 production in HUVECs. HUVECs were incubated for 48 hrs with supernatants of control (Ctrl) or IgGs
cross-linked human neutrophils (Stimulated) prepared as described in Material and Methods. A: The presence of ICAM-1 on HUVECs was
measured by flow cytometry. HUVECs were washed with PBS and detached by 5 minutes incubation with accutase at 37°C. Cells were
centrifuged, resuspended in HBSS/0.005% BSA and incubated with anti-ICAM-1 antibody (10 μg/ml) for 1 hour at 4°C before wash. They were
then incubated with the secondary anti-mouse FITC-conjugated antibody (1/100) for 30 minutes at 4°C, washed and fluorescence was analysed.
B: IL-8 release by HUVECs was measured by ELISA. The supernatants of HUVECs were collected and the remaining cells were discarded by centrifugation.
The amount of IL-8 in the supernatants was measured in duplicates using the human IL-8 CytoSet from Invitrogen (catalog no.CHC1303) following the
manufacturer’s instructions. IL-8 contained in neutrophils supernatants was substracted. Results are expressed as mean +/− SEM of three independent
experiments. * = P < 0.05 (one-sample t test).
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periment is performed in 96-well plates and consequently
requires low amounts of RF. We first characterized the
immunoglobulin composition of the RF preparation.
An aliquot was submitted to SDS-PAGE followed by
immunoblotting with anti-human IgG or anti-human
IgM. We observed that this RF preparation is an IgM/IgG
complex containing 5% IgM and 95% IgG, as estimated
by densitometry (Figure 6A). Thus, the complexes col-
lected using 5% PEG are the IgM-RFs bound to their
cognate IgG antigen. Being a pentamer, IgM-RFs pref-
erentially form immune complexes in the presence of
IgGs. As the methods used to dissociate IgMs from
IgGs (acid, high salt) can cause denaturation of the
RF with resulting loss of binding activity, we used in
the subsequent experiments the native RF preparation
as so. We incubated neutrophils with the RF complexes
and monitored their adhesion to HUVECs as in Figure 4.
To assess that RF can bind membrane-bound IgGs, we
performed these experiments without or with a pre-
incubation of neutrophils with PPP on the adhesion
capacity (see Figure 1). We observed an increase of
adhesion to HUVECs when neutrophils were incubated
with 500 μg/ml of purified RF and this adhesion was
enhanced when neutrophils were pre-incubated with PPP
(Figure 6B). This observation confirms the hypothesis that
RFs can bind IgGs on neutrophils leading to cell activation.
Adhesion was not modified in the presence of commercial
non-specific IgM alone (data not shown). The relatively
high concentration of RFs required for observing a func-
tional effect when compared with the commercial anti-
human cross-linking antibodies (20 μg/ml) is explained
by the low concentration of IgM-RFs present in thepreparation. Furthermore, as the affinity of most IgM-RFs
for IgG is relatively low (of the order of 105 to 107) there is
a constant on/off binding of the IgG-RF to IgGs or FcγR-
bound IgGs. As we showed that the RF preparation was an
IgG-containing complex, we tested the capacity of IgG
complexes to enhance adhesion. Incubation of neutrophils
with heat-agregated IgGs (HA-IgGs, 100 μg/ml) enhances
their adhesion to HUVECs in an FcγRs-dependent manner
(Figure 6C). Taken together, these results indicate that RFs
from RA patients can activate neutrophils by recognizing
either IgGs or FcγRs on neutrophils leading to an increased
adhesion to endothelium.
Discussion
The mechanisms neutrophils use to kill microorganisms
have the potential to alter or injure normal tissues [27].
Neutrophils’ Fcγ receptors illustrate this paradox. The best
described role for neutrophils’ FcγRs is the optimization
of the phagocytosis of IgG-opsonized pathogens [42-46].
However, these receptors are also involved in a variety of
IgG-dependent processes including clearance of the natur-
ally occurring immune complexes and the pathogenesis of
auto-immune disorders such as RA [13]. Although RFs are
present in the serum of the majority of RA patients and are
a predictor of disease severity, their potential role in FcγRs
activation and in RA pathogenesis is poorly characterized
[47,48]. Yet, as IgG-IgM complexes (see Figure 6), RFs
complexes represent potential ligands for FcγRs or for
IgGs bound to FcγRs.
We observed that incubation of neutrophils with a
preparation of RFs enhanced their ability to adhere to
HUVECs. To our knowledge, this result represents the first
observation of a biological effect of human RFs which could
Figure 6 Rheumatoid factors induce FcγRs-dependent adhesion
of neutrophils to HUVECs. A: An aliquot of the preparation of
rheumatoid factors (100 ng and 10 ng) was analyzed by SDS-PAGE
followed by immunoblotting with horseradish peroxidase-labelled
anti-human IgG or anti-human IgM antibodies. The same amounts
of commercial human IgG and IgM were analyzed on the same gel.
The IgM band was used for quantification (arrow). B: Neutrophils
were incubated with calcein and with or without PPP, as described
in Methods. Neutrophils were then plated on a confluent monolayer
of endothelial cells and RFs (500 μg/ml) were added for 2 hours.
Non-adherent neutrophils were discarded and the amount of
adherent cells was quantified as the amount of fluorescence bound
to endothelial cells. Results are expressed as mean +/− SEM of three
independent experiments. ** = P < 0.005, *** = P < 0.0005
(one-sample t test). C: Heat aggregated IgGs (HA-IgGs) were prepared as
previously described [41]. Neutrophils were incubated with calcein,
plated on endothelial cells and 100 μg/ml HA-IgG (HA) were added for 2
hours. Results are expressed as mean +/− SEM of three independent
experiments, each carried out in triplicate. ** = P < 0.005, *** = P < 0.0005
(Mann–Whitney test).
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addition, we showed that activation of FcγRs of neutrophils
with anti-human IgG antibodies which mimick the
presence of RFs leads within 30 minutes to an extracellular
release of lysosyme and superoxide anions concomitant
with an enhancement of the adhesion of neutrophils to
endothelial cells. These events may end up damaging the
endothelium, a possibility supported by our observation
that supernatants of neutrophils in which FcγRs have been
cross-linked altered the phenotype of endothelial cells in an
inflammatory direction (increased expression of ICAM-1
and production of IL-8). As IL-8 is a potent chemotactic
mediator for neutrophils, the combined increase of IL-8
and ICAM-1 will lead to a positive activation loop of re-
cruitment and adhesion of neutrophils with the potential
to induce local vascular injury.
Few studies have characterized blood neutrophils of
RA patients in spite of the demonstrated presence of
circulating IC. Chronic peripheral activation of neutro-
phils in polyarticular juvenile RA has been reported and
data suggest that blood neutrophils from RA patients
have impaired FcγR-dependent bactericidal functions
(superoxide production) [49,50]. On the other hand, gen-
eration of mice with neutrophil-selective expression of
FcγRIIa and FcγRIIIb indicate that, in a model of soluble
immune complexes deposited in the vasculature, FcγRIIIb
is responsible for slowing down neutrophils thereby facili-
tating adhesion to endothelial cells [13,26]. Immobilized
neutrophils may then activate FcγR-dependent cytotoxic
functions and promote local endothelium damage.
In innate immunity, by contrast, the vascular wall is
rarely in contact with the toxic products of neutrophils
as neutrophils leave the circulation by transendothelial
migration. They arrive at the inflammation site where
they release radical oxygen species and granular con-
tents, most often in phagosome, thus preventing major
damage to the cellular environment.
In humans, a similar mechanism of activation of FcγRs
on circulating neutrophils has previously been described in
anti-neutrophil cytoplasm autoantibody (ANCA)-associated
diseases. These antibodies activate circulating neutrophils
leading to vascular inflammation, a process in which FcγRs
are directly involved. ANCAs are directed against en-
zymes stored in neutrophil granules but which have
translocated to the plasma membrane in response to a
minor inflammatory stimulus. The F(ab’)2 portion of
ANCAs engages the antigen and the Fc portion engages
FcγRs. This FcγR-mediated interaction is required for
neutrophil activation [51,52]. This mode of stimulation
of neutrophils by ANCAs closely mimicks the mode of
stimulation of RF proposed in the present study and
argues for a role of RFs and RF-containing IC in RA-
associated vascular inflammation. ANCAs-associated
diseases, such as Wegener granulomatosis, clearly indicate
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lar inflammation.
We showed that the circulating neutrophils possess
membrane-bound IgGs which may be recognized by RFs
leading to their activation. The mechanism of action of
RF may require both the direct recognition of RF com-
plexes by free FcγRs, such as HA-IgG and the binding of
membrane-bound IgGs by RFs as pre-incubation of neu-
trophils with PPP enhances the RF-dependent activation
of neutrophils.
Several data suggest that the affinity of FcγRIIa may be
modulated by a priming signal such as fMLP, TNF or a
mechanism including granular proteases [53,54]. This is
of particular relevance in the inflammatory context of
arthritis where elevated concentrations of various cytokines
and mediators are present and may activate circulating neu-
trophils. A cytokine-dependent increase of FcγRs affinity
would influence the amount of membrane-bound IgGs and
consequently the RF-dependent activation of neutrophils of
RA patients. Of direct relevance to the present study, the
efficiency of anti-TNF therapy is related to a loss of func-
tion of FcγRIIa [21]. This effect may be mediated by the
ability of TNF to modulate the functional responsiveness of
FcγRIIa [55] and may, at least in part, explain the positive
effects of anti-TNF therapy on endothelial dysfunction as
previously proposed [56].
In the present study, we used a RF preparation puri-
fied from the sera of RA patients. This RF containing
preparation is polyclonal, i.e., that it contained different
populations of RFs (IgM and possibly IgG) with different
specificities and affinities. The affinity of RFs for IgGs
combined with the modulation of FcγR affinity for IgG
by RA-associated cytokines will impact on the FcγR-
dependent activation of neutrophils and consequently
on the inflammation of the endothelium observed in
RA patients. Further experiments using neutrophils
from RA patients untreated or treated with anti-TNF
therapy should help to understand not only the role of
RA-associated cytokines on FcγR activity, but also the
role of RF in the pathogenesis of RA.
In RA patients, high concentrations of RFs and the
presence of extra-articular manifestations such as vasculitis
are predictors of increased mortality, primarily from cardio-
vascular diseases [57]. Patients with ANCA-associated
diseases (Wegener granulomatosis) also present higher
risks to develop cardiovascular diseases [58]. On the
other hand, FcγRs have been proposed to play a critical
role in atherogenesis. Indeed, in apoE−/−mice (a model
of human atherosclerosis), FcγRs appear to be important
for the clearance of LDL-containing IC and apoE−/− mice
deficient for the activating γ chain of FcγRs show less
development and progression of atherosclerosis than
apoE−/− mice which possess the γ chain of FcγRs [59].
These data support a role for leukocytes’ FcγRs incardiovascular diseases associated with auto-immune
diseases.
Systemic lupus erythematosus (SLE) is a chronic inflam-
matory disease also characterized by systemic inflamma-
tion and the presence of auto-antibodies and RF. Patients
with SLE have an increased mean intima media thickness
and SLE represents a risk factor for cardiovascular disease
[60,61]. This indicates that the engagement of FcγRs of
neutrophils and other immune cells may be involved in
vascular dysfunction associated with various auto-immune
inflammatory diseases.
Further examinations of neutrophil responses to RFs
isolated from different patients are warranted. Indeed,
the Ig composition, the affinity and the size of the RF
complexes could influence neutrophil activation. Never-
theless, our results present a first report underlining the
role of RFs in FcγR-dependent activation of circulating
neutrophils and the potential consequences on systemic
vascular inflammation. We previously characterized several
of the pathways downstream of neutrophil’s FcγRs and
we showed that both receptors cooperate for optimal
FcγR-dependent responses [62,63]. In particular, FcγRIIIb
activation triggers a specific calcium signal [41]. As
FcγRIIIb is nearly exclusively expressed on human neu-
trophils, targeting this receptor or the FcγRIIIb-dependent
calcium signal, may represent an interesting clinical avenue
which could help control RF-associated systemic inflamma-
tion in RA patients.
Conclusions
We show here that rheumatoid factors either by recog-
nizing membrane-bound IgGs or by direct binding to
FcγRs can activate circulating neutrophils. As this activa-
tion leads to adhesion to endothelial cells and may mod-
ify the phenotype of endothelial cells, we propose that it
participates in the rheumatoid arthritis-associated vascu-
lar damages.
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